Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 15/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 14/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18936123 | 0.82 | BRD4 (0.33) | — | |
| SCHEMBL4046834 | 0.77 | TRPA1 (0.44) | TRPA1CYP11B1CYP11B2ESR2TSHR | |
| SCHEMBL17069064 | 0.76 | ABCG2 (0.44) | TRPA1CYP11B1CYP11B2TSHRKDM4E | |
| SCHEMBL7128137 | 0.76 | ITGB2 (0.44) | TRPA1CYP11B1CYP11B2KDM4E | |
| SCHEMBL18936028 | 0.73 | TRPA1 (0.44) | TRPA1CYP11B1CYP11B2ESR2TSHR | |
| SCHEMBL18936117 | 0.72 | MAP3K14 (0.37) | ALDH1A1 | |
| SCHEMBL8191555 | 0.72 | CA2 (0.40) | — | |
| SCHEMBL18936102 | 0.72 | CHRNB4 (0.37) | ALDH1A1 | |
| SCHEMBL14829341 | 0.72 | AHR (0.44) | — | |
| SCHEMBL9618582 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10251396-B2 | Amide compound and use of same for noxious arthropod control | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-04-09 | — | — | US | disclosed |
| US-20170295789-A1 | AMIDE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-10-19 | — | — | US | disclosed |
| EP-3178322-A1 | AMIDE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL | Sumitomo Chemical Company Limited (JP) | 2017-06-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170295789-A1 | AMIDE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL | OPRM1, TRPA1, L3MBTL3 | TRPA1 2/4885CYP11B1 3200/4885CYP11B2 3177/4885 |
| US-10251396-B2 | Amide compound and use of same for noxious arthropod control | OPRM1, TRPA1, L3MBTL3 | TRPA1 2/4885CYP11B1 3200/4885CYP11B2 3177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.